# A Study of TAK-510 in Healthy Adults

> **NCT04731922** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 124 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** TAK-510
- **DRUG:** TAK-510 Placebo

## Key facts

- **NCT ID:** NCT04731922
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-03
- **Primary completion:** 2022-07-24
- **Final completion:** 2022-07-24
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2024-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04731922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04731922, "A Study of TAK-510 in Healthy Adults". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04731922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*